OR WAIT null SECS
June 01, 2020
The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.
May 19, 2020
HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.
May 15, 2020
A contamination control strategy can prevent contamination in sterile product manufacturing. The right system, equipment, and personnel training are also essential to mitigate risk.
Pharmaceutical Technology spoke with John Harmer, director, technical sales at Vanrx Pharmasystems about considerations in choosing the best system and equipment for contamination control in pharmaceutical manufacturing.
A variety of assays should be used to detect bacterial, fungal, and viral contaminants in the human source cells used for cell therapies.
Regulators have exaggerated expectations for simulated media fills.
May 02, 2020
Organizations involved in aseptic and sterile processing activities must make an effort to comply with current good manufacturing practices.
A well-defined contamination control program is essential to maintain quality through aseptic manufacture of parenteral drug products.
April 02, 2020
Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.
February 02, 2020
Consider equipment design, transfer systems, and maintenance when operating isolators for sterile manufacturing of pharmaceutical products.